Dudediligence.

Jasper Therapeutics, Inc

JSPRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

28.1M

on 2026-06-30, from 15.1M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

10M20M30MMar2024JunSepDecMar2025JunSep$2.43DecMar2026Jun

Newest

S-3 of 2025-03-19. Not read yet. S-3 ↗

3 of its filings are not read yet.

Warrants

675K

Warrants of every class as tagged in the XBRL facts on 2025-09-30, exercise price $0.0001. 10-Q ↗

Cash

0.5 quarters

$7.3M on 2026-06-30 ÷ $15.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-09-19Public offering incl. 0.68M pre-funded12,345,707$2.43$30.0M424B5 ↗